Effective treatment for advanced hepatocellular carcinoma with portal venous invasion using a combination therapy of intra-arterial 5-fluorouracil and subcutaneous pegylated-interferon-alpha-2b

Hepato-Gastroenterology

Volumn 55, Issue 86-87, 2008, Pages 1776-1777

  Mawatari, Hironori ^a   Kirikoshi, Hiroyuki ^a   Yoneda, Masato ^a   Higurashi, Takuma ^a   Fujita, Koji ^a   Saito, Satoru ^a   Inamori, Masahiko ^a   Takahashi, Hirokazu ^a   Abe, Yasunobu ^a   Kubota, Kensuke ^a   Nakajima, Atsushi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

5 Fluorouracil; Hepatocellular carcinoma; Pegylated interferon alpha 2b

Indexed keywords

FLUOROURACIL; PEGINTERFERON ALPHA2B;

ADVANCED CANCER; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER INVASION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG RESPONSE; ECHOGRAPHY; FOLLOW UP; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; MALE; MULTIPLE CYCLE TREATMENT; PORTAL VEIN; PRIORITY JOURNAL; QUALITY OF LIFE; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, HEPATOCELLULAR; FLUOROURACIL; HUMANS; INFUSIONS, INTRA-ARTERIAL; INJECTIONS, SUBCUTANEOUS; INTERFERON ALFA-2B; LIVER NEOPLASMS; MALE; NEOPLASM INVASIVENESS; PORTAL VEIN; QUALITY OF LIFE;

EID: 57049089462     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Obi S, Yoshida H, Toune R, Unuma T, Kanda M, Sato S, Tateishi R, Teratani T, Shiina S, Omata M: Combination therapy of intra-arterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion. Cancer 2006; 106:1990-1997.
2. Enjoji M, Morizono S, Kotoh K, Kohjima M, Miyagi Y, Yoshimoto T, Nakamuta M: Re-evaluation of antitumor effects of combination chemotherapy with interferon-alpha and 5-fluorouracil for advanced hepatocellular carcinoma. World J Gastroenterol 2005; 11:5685-5687.
3. Patt YZ, Hassan MM, Lozano RD, Brown TD, Vauthey JN, Curley SA, Ellis LM: Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma. J Clin Oncol 2003; 21:421-427.
4. Kurokohchi K, Takaguchi K, Kita K, Masaki T, Kuriyarna S: Successful treatment of advanced hepatocellular carcinoma by combined administration of 5-fluorouracil and pegy1ated interferon-alpha. World J Gastroenterol 2005; 11:5401-5403.